Magnetic resonance imaging for staging cervical and endometrial cancer
Medical Services Advisory Committee
Record ID 32002000525
English
Authors' objectives:
This report aims to assess the effectiveness of magnetic resonance imaging (MRI) for staging cervical and endometrial cancer.
Authors' recommendations:
MSAC recommends on the strength of evidence pertaining to Magnetic Resonance Imaging (MRI) for staging of cervical and endometrial cancer that:
1. Public funding should be supported for MRI staging of histologically proven cervical cancer at FIGO stages IB or greater following assessment by examination under anaesthesia;
2. At present there is insufficient evidence to support public funding for MRI in patients with recurrent cervical cancer but further studies may require this issue to be reviewed in the future; and
3. Public funding should not be supported for MRI staging of endometrial cancer at this time.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.msac.gov.au/reports.htm
Year Published:
2001
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Magnetic Resonance Imaging
- Neoplasm Staging
- Endometrial Neoplasms
- Uterine Cervical Neoplasms
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.